![SpectraCure AB (publ) logo](/logos/SPEC.ST.webp)
SpectraCure AB (publ)
SSE:SPEC.ST
Overview | Financials
Company Name | SpectraCure AB (publ) |
Symbol | SPEC.ST |
Currency | SEK |
Price | 2.605 |
Market Cap | 253,027,818 |
Dividend Yield | 0% |
52-week-range | 2.225 - 6.6 |
Industry | Medical Devices |
Sector | Healthcare |
CEO | Dr. Masoud Khayyami Ph.D. |
Website | https://www.spectracure.com |
An error occurred while fetching data.
About SpectraCure AB (publ)
SpectraCure AB (publ) focuses on cancer treatment utilizing laser light sources and photo reactive drugs. It develops IDOSE software with interstitial photodynamic therapy system, which is in Phase II clinical trial for the treatment of solid tumors. The company was founded in 2003 and is based in Lund, Sweden.
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD